An aviation fuel company in Great Falls will soon receive its first installment of a nearly $1.7 billion loan from the ...

Skepta has been nominated for the prestigious International Artist of the Year category at the 2025 Headies Awards for his ...

The judge said Regier consistently during the 2023 session denied relying on political considerations and told others he didn't know how to check the partisan lean of his proposed districts.

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Leaders in the Montana Legislature as well as the Department of Public Health and Human Services contemplate revamping ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

Scott Applewhite, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] WASHINGTON (AP) — The Supreme Court on Tuesday turned back an election law case out of Montana that relied ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

Will Medicare end Novo Nordisk's obesity drug boom? It's not surprising that CMS chose Ozempic, Wegovy, and Rybelsus for Medicare drug price negotiations. Between November 2023 and October 2024 ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...